All4NutraNo products in the cart.
All4NutraStartseite » DC excipient » Page 25
The efficient development of robust tableting processes is challenging due to the lack of mechanistic understanding on the impact of...
Acid-modified tapioca starches (AMTSs) possessed good compressibility but showed poor particle flowability for preparing tablets by the direct compression method....
The present study involves designing a delayed-release tablet formulation of a drug belonging to BCS class-III further chemically classified as...
In the present study, the performance of PROSOLV® EASYt ab SP was tested in four DC formulations with different model...
The objective of the present study was to develop microballoons aided gastro-retentive floating tablets of baclofen, a skeletal muscle relaxant...
Pharmaceutical tablet productions by direct compaction (DC) are more environmentally sustainable than wet granulation (WG) owed to DC’s lower energy...
Ticagrelor is a new generation Adenosine diphosphate receptor inhibitor drug which is highly lipohilic having poor aqueous solubility used in...
Reliable and stable tablet formulations for rosuvastatin calcium in four strengths: 5 mg, 10 mg, 20 mg and 40 mg have been developed. Rosuvastatin...
Hydralazine hydrochloride is an anti-hypertensive drug. The drug has poor oral bioavailability (BA) of about 30- 50% due to extensive...
The 12th APV PBP World Meeting took place from 28 – 31 March 2022 in Rotterdam. There was a poster section at...
Copyright: PharmaExcipients AG